Isotiorga (Isotretinoin)

Isotretinoin binds to nuclear retinoic acid receptors, altering gene expression that controls cell differentiation and proliferation in the skin. This reduces sebaceous gland size, lowers sebum output, and exerts anti‑inflammatory effects, thereby addressing the underlying pathophysiology of severe acne.

The dosage of isotretinoin is individualized by the prescribing clinician based on the patient’s weight, severity of acne, and laboratory results. The prescriber determines the appropriate daily amount and treatment duration, typically ranging from several weeks to months.

Isotiorga is classified as pregnancy category X because isotretinoin is highly teratogenic. It must not be used by pregnant women or women who may become pregnant, and effective contraception is required. Use during breastfeeding is also contraindicated due to potential harm to the infant.

To request Isotiorga, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with oral antibiotics or hormonal therapy, isotretinoin offers a disease‑modifying effect by targeting sebum production rather than merely reducing bacterial growth. It is generally reserved for severe, treatment‑resistant acne because of its potent efficacy and higher risk profile.

Keep Isotiorga at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, excessive heat and direct light to maintain stability throughout the shelf life.

Isotiorga is taken orally, usually with a meal to improve absorption. The tablet should be swallowed whole with water and not chewed or broken, unless the prescriber provides specific instructions.

The most critical risks include severe depression or suicidal ideation, teratogenic birth defects if exposure occurs during pregnancy, and rare but serious conditions such as pancreatitis and significant liver enzyme elevation. Immediate medical attention is required if these occur.

Isotiorga is contraindicated in pregnant or nursing women, patients with known hypersensitivity to isotretinoin or other retinoids, and individuals with uncontrolled hyperlipidemia or severe liver disease. It should also be avoided in patients taking other vitamin A derivatives.